These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


379 related items for PubMed ID: 29027133

  • 21. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
    Wang L, Jia E.
    Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
    [Abstract] [Full Text] [Related]

  • 22. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells.
    Tran TH, Choi JY, Ramasamy T, Truong DH, Nguyen CN, Choi HG, Yong CS, Kim JO.
    Carbohydr Polym; 2014 Dec 19; 114():407-415. PubMed ID: 25263908
    [Abstract] [Full Text] [Related]

  • 23. Functionalized nanospheres for targeted delivery of paclitaxel.
    Bushman J, Vaughan A, Sheihet L, Zhang Z, Costache M, Kohn J.
    J Control Release; 2013 Nov 10; 171(3):315-21. PubMed ID: 23792807
    [Abstract] [Full Text] [Related]

  • 24. Low-dose paclitaxel via hyaluronan-functionalized bovine serum albumin nanoparticulate assembly for metastatic melanoma treatment.
    Chen X, Wang M, Hu Y, Gong T, Zhang ZR, Yu R, Fu Y.
    J Mater Chem B; 2020 Mar 11; 8(10):2139-2147. PubMed ID: 32090232
    [Abstract] [Full Text] [Related]

  • 25. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E, Kumar R, Saladi S, Rafeeqi TA, Khan W.
    Colloids Surf B Biointerfaces; 2016 Jul 01; 143():532-546. PubMed ID: 27045981
    [Abstract] [Full Text] [Related]

  • 26. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
    Zou J, Su S, Chen Z, Liang F, Zeng Y, Cen W, Zhang X, Xia Y, Huang D.
    Artif Cells Nanomed Biotechnol; 2019 Dec 01; 47(1):3456-3464. PubMed ID: 31469318
    [Abstract] [Full Text] [Related]

  • 27. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L, Yao J, Zhou J, Wang T, Zhang Q.
    Int J Pharm; 2013 Jan 30; 441(1-2):654-64. PubMed ID: 23117024
    [Abstract] [Full Text] [Related]

  • 28. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
    Baek JS, Cho CW.
    Int J Pharm; 2015 Jan 30; 478(2):617-24. PubMed ID: 25510604
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
    Wang R, Yang M, Li G, Wang X, Zhang Z, Qiao H, Chen J, Chen Z, Cui X, Li J.
    Colloids Surf B Biointerfaces; 2019 Feb 01; 174():270-279. PubMed ID: 30469048
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
    Hu H, Lin Z, He B, Dai W, Wang X, Wang J, Zhang X, Zhang H, Zhang Q.
    J Control Release; 2015 Dec 28; 220(Pt A):189-200. PubMed ID: 26474677
    [Abstract] [Full Text] [Related]

  • 34. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
    Ravar F, Saadat E, Gholami M, Dehghankelishadi P, Mahdavi M, Azami S, Dorkoosh FA.
    J Control Release; 2016 May 10; 229():10-22. PubMed ID: 26968799
    [Abstract] [Full Text] [Related]

  • 35. Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma.
    Xia J, Du Y, Huang L, Chaurasiya B, Tu J, Webster TJ, Sun C.
    Nanomedicine; 2018 Apr 10; 14(3):713-723. PubMed ID: 29317344
    [Abstract] [Full Text] [Related]

  • 36. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R, Van Woensel M, Gelbcke M, Mathieu V, Hecq J, Mathivet T, Vermeersch M, Van Antwerpen P, Amighi K, Wauthoz N.
    Mol Pharm; 2018 Mar 05; 15(3):899-910. PubMed ID: 29341619
    [Abstract] [Full Text] [Related]

  • 37. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang Y, Wang S, He Z.
    Int J Pharm; 2011 Dec 12; 421(1):160-9. PubMed ID: 21945183
    [Abstract] [Full Text] [Related]

  • 38. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
    Sahu PK, Mishra DK, Jain N, Rajoriya V, Jain AK.
    Drug Dev Ind Pharm; 2015 Apr 12; 41(4):640-9. PubMed ID: 24564799
    [Abstract] [Full Text] [Related]

  • 39. pH-Responsive NIR-Absorbing Fluorescent Polydopamine with Hyaluronic Acid for Dual Targeting and Synergistic Effects of Photothermal and Chemotherapy.
    Kim SH, In I, Park SY.
    Biomacromolecules; 2017 Jun 12; 18(6):1825-1835. PubMed ID: 28481511
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.